ArticleTechnology in cancer research & treatment
The Role of Using Machine Learning Algorithms in Non-contrast CT Based Images in Determining Pathological Subtypes of Lung Cancer.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionLung cancer is a common cancer with a high mortality rate worldwide. Significant differences in treatment, prognosis, and recurrence rates exist depending on lung cancer subtype. The goal of our study is to use machine learning models based on chest computed tomography (CT) scans to predict tumor subtypes.MethodsA total of 99 lung cancer cases with histopathological tissue diagnosis were included in this retrospective, single-center study. Tumor segmentation was performed in three-dimension (3D) using mediastinal and parenchymal windows on a chest CT, and 180 features were extracted, of which 90 were retained after recursive feature elimination (RFE). Due to class imbalance, model performance was tested using a stratified folding method. Machine learning (ML) algorithms CatBoost, XGBoost, and Ensemble models were trained separately on parenchymal and mediastinal window feature sets.ResultsThe most common type of lung cancer among patients was adenocarcinoma (AC) in the non-small cell lung cancer (NSCLC) group (n=57, 57.58%). When compared to XGBoost and Ensemble models, CatBoost demonstrated superior performance in differentiating between small cell lung cancer (SCLC) and NSCLC, achieving 90% accuracy and an 80.39% area under the curve (AUC). The Ensemble model, also trained with the parenchymal window, achieved the highest accuracy in distinguishing adenocarcinoma from other lung cancers (non-adenocarcinoma), with 75% accuracy and 72.92% AUC, respectively.ConclusionIn summary, our research has demonstrated that machine learning (ML) algorithms can accurately determine lung cancer tumor subtypes, eliminating the need for additional invasive procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.